The Q3 beat on RoTE and EPS, combined with the £500m buyback and reaffirmed 2026/2028 targets, signals continued operational momentum. Watch for Q4 2026 structural cost actions (c.£300m planned) and the impact of Basel 3.1 implementation on CET1 ratio in early 2027.
Price Chart
Executive Summary
Barclays PLC reported Q3 2026 results with Group RoTE of 11.7% (up from 10.6% in Q3 2025), EPS of 12.3p (up 18% YoY), and announced a £500m share buyback. Profit before tax rose 12% YoY to £2.3bn, driven by income growth of 3% and a 20% reduction in credit impairment charges. The bank reaffirmed its 2026 RoTE target of >12% and 2028 RoTE target of >14%, while guiding for FY26 total costs of c.£18.5bn and FY27 costs of c.£18.4bn.
Key Facts
- Q3 2026 Group RoTE of 11.7% vs 10.6% in Q3 2025; YTD RoTE of 13.8% vs 12.3%
- Q3 2026 EPS of 12.3p, up 18% YoY; YTD EPS of 43.0p, up 23% YoY
- Profit before tax of £2.3bn in Q3 2026, up 12% YoY
- Group income of £7.4bn in Q3 2026, up 3% YoY
- Credit impairment charges of £0.5bn in Q3 2026, down 20% YoY; loan loss rate of 43bps vs 57bps
- CET1 ratio of 14.2%; announced £500m share buyback, bringing YTD announced distributions to £2.8bn, up 46% YoY
- Equities income up 47% YoY in Q3 2026; FICC income down 19% YoY
- FY26 total costs guided to c.£18.5bn; FY27 total costs guided to c.£18.4bn
- 2028 RoTE target of >14%; 2026-2028 capital return plan of >£15bn
- Basel 3.1 implementation expected from 1 Jan 2027 with c.8-15bn RWA increase and 59bps Pillar 2A reduction
Financial Impact
Q3 2026 attributable profit of £1.6bn, up 13% YoY; YTD attributable profit of £5.8bn, up 17% YoY
Risk Factors
- FICC revenue declined 19% YoY in Q3 2026, reflecting challenging market conditions
- RWAs expected to increase by 8-15bn on 1 Jan 2027 from Basel 3.1, reducing CET1 ratio by 30-55bps
- Motor finance redress provision of £430m remains subject to legal challenges and regulatory uncertainty
- USCB RoTE declined to 10.9% in Q3 2026 from 13.5% in Q3 2025 due to Best Egg acquisition costs
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0000312069-26-000240 |
| Document: bplc6-kexhibit992q326.htm | 0000312069-26-000240 |
| Document: bplc6-kcoverpageq326.htm | 0000312069-26-000240 |
| Document: 0000312069-26-000240-index-headers.html | 0000312069-26-000240 |
| Document: 0000312069-26-000240-index.html | 0000312069-26-000240 |
| Document: 0000312069-26-000240.txt | 0000312069-26-000240 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | 6-K | $21.74 | awaiting T+20 | awaiting T+20 | $22.46 (+3.31%) |
Oct 22, 2026 5d ago | 6-K | $22.01 | awaiting T+20 | awaiting T+20 | $22.46 (+2.04%) |
Oct 22, 2026 5d ago | 6-K | $22.01 | awaiting T+20 | awaiting T+20 | $22.46 (+2.04%) |
Oct 9, 2026 18d ago | 6-K | $22.95 | awaiting T+20 | awaiting T+20 | $22.46 (−2.14%) |
Oct 1, 2026 26d ago | 6-K | $23.64 | awaiting T+20 | awaiting T+20 | $22.46 (−4.99%) |
Sep 24, 2026 4w ago | 6-K | $24.43 $22.01 | ▼ −9.91% | ▼ −9.49% | $22.46 (−8.06%) |
Sep 18, 2026 5w ago | 6-K | $24.87 $22.79 | ▼ −8.36% | ▼ −8.57% | $22.46 (−9.69%) |
Sep 11, 2026 6w ago | 6-K | $26.70 $22.95 | ▼ −14.04% | ▼ −15.91% | $22.46 (−15.88%) |
Sep 9, 2026 6w ago | 6-K | $26.44 $23.00 | ▼ −13.01% | ▼ −14.95% | $22.46 (−15.05%) |
Sep 1, 2026 8w ago | 6-K | $26.15 $24.27 | ▼ −7.19% | ▼ −7.51% | $22.46 (−14.11%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers